$27.99
5.27% day before yesterday
Nasdaq, Jan 02, 10:05 pm CET
ISIN
US98419J2069
Symbol
XOMA

XOMA Corporation Stock price

$27.99
-1.77 5.95% 1M
+1.88 7.20% 6M
+1.40 5.27% YTD
+1.99 7.65% 1Y
+9.59 52.12% 3Y
-11.83 29.71% 5Y
+1.19 4.44% 10Y
-452.01 94.17% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+1.40 5.27%
ISIN
US98419J2069
Symbol
XOMA
Industry

Key metrics

Basic
Market capitalization
$346.6m
Enterprise Value
$408.6m
Net debt
$62.0m
Cash
$46.7m
Shares outstanding
12.3m
Valuation (TTM | estimate)
P/E
51.8 | 25.2
P/S
7.4 | 6.9
EV/Sales
8.7 | 8.1
EV/FCF
negative
P/B
3.2
Financial Health
Equity Ratio
37.0%
Return on Equity
-23.6%
ROCE
4.2%
ROIC
6.4%
Debt/Equity
1.0
Financials (TTM | estimate)
Revenue
$47.1m | $50.5m
EBITDA
$12.1m | $15.6m
EBIT
$9.9m | $11.0m
Net Income
$9.9m | $13.7m
Free Cash Flow
$-14.7m
Growth (TTM | estimate)
Revenue
103.9% | 77.3%
EBITDA
164.6% | 395.2%
EBIT
152.4% | 300.6%
Net Income
123.3% | 171.0%
Free Cash Flow
0.7%
Margin (TTM | estimate)
Gross
-
EBITDA
25.8% | 30.8%
EBIT
20.9%
Net
21.0% | 27.1%
Free Cash Flow
-31.2%
More
EPS
$0.5
FCF per Share
$-1.2
Short interest
5.2%
Employees
13
Rev per Employee
$2.2m
Show more

Is XOMA Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

XOMA Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a XOMA Corporation forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a XOMA Corporation forecast:

Buy
80%
Hold
20%

Financial data from XOMA Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
47 47
104% 104%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 33 33
17% 17%
69%
- Research and Development Expense 2.30 2.30
11% 11%
5%
12 12
165% 165%
26%
- Depreciation and Amortization 2.28 2.28
22,700% 22,700%
5%
EBIT (Operating Income) EBIT 9.85 9.85
152% 152%
21%
Net Profit 9.87 9.87
123% 123%
21%

In millions USD.

Don't miss a Thing! We will send you all news about XOMA Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

XOMA Corporation Stock News

Neutral
GlobeNewsWire
12 days ago
EMERYVILLE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty's Series A and Series B Cumulative Preferred Stock: Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash div...
Neutral
GlobeNewsWire
29 days ago
EMERYVILLE, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA), the biotech royalty aggregator, today announced it has successfully completed its previously announced acquisition of the entire issued and to be issued share capital of Mural Oncology plc (“Mural”) (Nasdaq: MURA) (the “Acquisition”) pursuant to an Irish High Court sanctioned scheme o...
Neutral
GlobeNewsWire
about one month ago
WALTHAM, Mass. and DUBLIN, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc, (Nasdaq: MURA) (“Mural”) announces that the High Court of Ireland has today sanctioned the scheme of arrangement between Mural and its shareholders under Chapter 1 of Part 9 of the Companies Act 2014 (the “Scheme”) pursuant to which XRA 5 Corp. (“Sub”), a wholly-owned subsidiary of XOMA Royalty Corporation (Nasdaq:...
More XOMA Corporation News

Company Profile

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Head office United States
CEO Owen Hughes
Employees 13
Founded 1981
Website xoma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today